Skip to search formSkip to main contentSkip to account menu

pamidronic acid

Known as: Acido pamidronico, Acidum pamidronicum, Acide pamidronique 
An amino- bisphosphonate with anti-resorptive and anti-hypercalcemic activities. Pamidronic acid binds to and adsorbs onto hydroxyapatite crystals in… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
Neridronate is an aminobisphosphonate, licensed in Italy for the treatment of osteogenesis imperfecta (OI) and Paget’s disease of… 
2012
2012
SummaryAbstractZoledronic acid (Zometa®), a third-generation amino-bisphosphonate, has been approved in the US, the EU and many… 
2011
2011
BACKGROUND In a third of patients presenting with rhabdomyolysis-induced acute renal failure (ARF), a biphasic plasma calcium… 
Review
2008
Review
2008
Zoledronic acid (Zometa is a third-generation nitrogen-containing parenteral bisphosphonate indicated for the treatment of bone… 
2006
2006
Background: In patients with metastatic non-small cell lung cancer (NSCLC), second-line chemotherapy induces response rates of… 
2003
2003
Ocular adverse effects of pamidronic acid are rare but well documented. Pamidronate, an inhibitor of bone resorption used… 
1991
1991
Three patients aged between 31 and 59 were treated with pamidronic acid (APD) due to severe hypercalcemia caused by parathyroid…